The caveman skincare trend on TikTok is clean beauty at its worst
The Paleo trend has come for your face: ' Caveman skin' is the latest beauty routine taking over social media. After circulating on Reddit for a few years, it was popularized this spring by Montreal-based TikTokker Tia Zakher, who went viral on the app for going about three months without putting anything on her face — no water, no cleanser, no moisturizer, nothing.
The idea is that it's an elimination diet for your skin; an epidermal reset, if you will. 'For years, I picked and over-exfoliated and damaged my skin really badly … My skin is basically shedding all the damage and attempting to reregulate itself,' Zakher says in a video about the trend. Over the course of her attempt, which she says she did with guidance from her dermatologist, her skin looks as if it's pilling and then peeling off.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Toronto Star
3 hours ago
- Toronto Star
Hundreds of laid-off CDC employees are being reinstated
NEW YORK (AP) — More than 460 laid-off employees at the nation's top public health agency received notices Wednesday that they are being reinstated, according to a union representing the workers. The U.S. Department of Health and Human Services confirmed reinstatement notices went out to the former Centers for Disease Control and Prevention employees, but provided few details. About 2,400 CDC employees lost their jobs in a wave of cuts across federal health agencies in early April, according to a tally at the time. ARTICLE CONTINUES BELOW Whole CDC programs were essentially shut down, including some focused on smoking, lead poisoning, gun violence, asthma and air quality, and workplace safety and health. The entire office that handles Freedom of Information Act requests was shuttered. Infectious disease programs took a hit, too, including programs that fight outbreaks in other countries, labs focused on HIV and hepatitis in the U.S., and staff trying to eliminate tuberculosis. An estimated 200 of the reinstated workers are based in the CDC's National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention, HHS officials confirmed. Staffers at a CDC lab that does testing for sexually transmitted diseases are being brought back, said one CDC employee who wasn't authorized to discuss what happened and spoke to The Associated Press on condition of anonymity. Also reinstated are an estimated 150 employees at the CDC's National Center for Environmental Health, including people staffing a lab that works on lead poisoning, according to the union and employees. Layoffs at federal agencies were challenged in lawsuits, with judges in some cases ordering federal agencies to halt terminations of employees. Officials at HHS have never detailed how they made the layoff decisions in the first place. And they did not answer questions about why the notices went out, or how decisions were made about who to bring back. HHS spokesperson Andrew Nixon said the agency was streamlining operations and that 'the nation's critical public health functions remain intact and effective.' ARTICLE CONTINUES BELOW ARTICLE CONTINUES BELOW 'The Trump Administration is committed to protecting essential services — whether it's supporting coal miners and firefighters through NIOSH, safeguarding public health through lead prevention, or researching and tracking the most prevalent communicable diseases,' he said. This is not the first time that employees at the Atlanta-based agency were told they were being terminated only to then be told to come back. After an earlier round of termination notices went out in February, about 180 CDC employees in March were told to come back. __ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
National Post
10 hours ago
- National Post
Genesys Capital is Closing its Largest Fund to Date – Genesys Ventures IV LP
Article content TORONTO & MONTREAL — Genesys Capital ('Genesys') is pleased to announce the upcoming closing of Genesys Ventures IV LP ('Fund IV' or the 'fund') to continue its successful track record of building Canadian life science companies in both the medtech and biotech sectors. Article content Genesys welcomes new Limited Partners into Fund IV and thanks returning LP's that engaged early, maintained unwavering support through the fundraising process, and provided catalytic commitments of scale to the fund, in the current context of an unprecedented, ever-changing macro environment. Fund IV institutional investors include: BDC Capital, Export Development Canada (EDC), Fonds de solidarité de la Fédération des travailleurs et travailleuses du Québec (FTQ), HarbourVest, Royal Bank of Canada, Teralys Capital, Venture Ontario, and the Government of Canada's Venture Capital Catalyst Initiative (VCCI), which is administered by BDC Capital under its Life Sciences Stream. Limited Partner commitment to the Genesys franchise and the Genesys investment thesis of co-creating and investing in disruptive Canadian life science opportunities has paid off as Genesys has delivered class leading performance and increasing DPI across its successive funds. Article content Genesys' value-added, partnership approach to working with scientific founders provides both capital and expertise to create companies that compete on a global scale. This has anchored Genesys as a local trusted source of deal flow for global syndicate partners and a first point of contact for repeat entrepreneurs. The team at Genesys has mastered its strategy that takes advantage of the opportunity that the innovation in Canada provides. Article content Genesys has a distinguished history of delivering upper quartile returns across its previous funds and has stepped up into upper decile in its third fund. Notable recent exits include Inversago Pharma, which was acquired by Novo Nordisk for $1.4 billion, and Fusion Pharmaceuticals, which exited to AstraZeneca for $3.3 billion. These successes highlight Genesys' ability to generate fund level returns driven by local Canadian innovation. Article content With this fund, Genesys Capital will continue to set the standard for life sciences venture capital in Canada, with a commitment to building world-class companies and delivering exceptional returns for its investors. Article content Quotes Article content 'EDC is proud to support Genesys Capital, an important funder of companies advancing life sciences in Canada. As healthcare continues its rapid global expansion, Canada stands out with its skilled talent base, early-stage research and development capacity, and strong presence in medtech and biotech. Genesys' approach of building anchor companies will foster enduring ecosystem clusters in Canada, help drive innovation and strengthen Canada's global competitiveness in this growing sector. We look forward to seeing the transformative impact of this fund.' Guillermo Freire, Senior Vice-President, Mid-Market Group, EDC. 'The Fonds de solidarité FTQ's reinvestment in Genesys Capital demonstrates our confidence in a strategic player in life sciences venture capital. With its in-depth knowledge of the Quebec ecosystem and its ongoing support for emerging local companies in biotechnology, Genesys actively contributes to the sector's competitiveness and innovation.' Maxime Pesant, Vice-President, Private Equity and Impact Investing – Life Sciences, at the Fonds de solidarité FTQ. 'Accessing Canadian life sciences investments through a long-term partner like Genesys supports innovation in the market. It is also a strategic move to diversify the Canadian economy and ensure global competitiveness in health and biotechnology, sectors that we believe have historically delivered competitive returns for our investors.' Senia Rapisarda, Managing Director, HarbourVest Partners. 'It is a great time to be investing out of a new fund, and we are looking forward to continuing to create best in class biopharmaceutical and medical technology companies that leverage local innovations.' Damian Lamb, Co-founder and Managing Director, Genesys Capital. 'We are pleased to recommit to the Genesys team and vision. Ontario is recognized as a leader in the life sciences sector and home to some of the sector's most innovative start-ups. The Genesys team, headquartered in Ontario, has a unique ability to identify high-potential companies and support them in becoming global leaders. We are excited about this continued partnership.' Steve Romanyshyn, President and Chief Executive Officer at Venture Ontario. 'Congratulations to the Genesys team. The government's approach of co-investing alongside private VC funds through the Venture Capital Catalyst Initiative is helping boost investment in emerging sectors. Today's announcement shows that Canadian life sciences innovation is going strong and getting the support it needs to compete.' The Honourable Mélanie Joly, Minister of Industry and Minister responsible for Canada Economic Development for Quebec Regions. About Genesys Genesys Capital is a Venture Capital Fund based in Toronto, investing in early-stage life sciences opportunities in areas of unmet medical need. With over 25 years of investment experience adhering to a consistent company creation investment strategy, Genesys has become the most successful life sciences venture firm in Canada. Article content Article content Article content Article content Article content Contacts
Toronto Star
a day ago
- Toronto Star
Would you ever just stop washing your face? Inside the viral ‘caveman beauty' trend
The Paleo trend has come for your face: ' Caveman skin' is the latest beauty routine taking over social media. After circulating on Reddit for a few years, it was popularized this spring by Montreal-based TikTokker Tia Zakher, who went viral on the app for going about three months without putting anything on her face — no water, no cleanser, no moisturizer, nothing. The idea is that it's an elimination diet for your skin; an epidermal reset, if you will. 'For years, I picked and over-exfoliated and damaged my skin really badly … My skin is basically shedding all the damage and attempting to reregulate itself,' Zakher says in a video about the trend. Over the course of her attempt, which she says she did with guidance from her dermatologist, her skin looks as if it's pilling and then peeling off.
